Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole Open Label Extension in Pediatric Tourette Syndrome
NCT00681863Phase 3Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- May 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of pramipexole in Tourette syndrome (TS), sponsored by Boehringer Ingelheim. Started May 2008; status: terminated.
02
Drugs
pramipexole
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT00681863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00681863.